AMIT KOLI - Academia.edu (original) (raw)
Related Authors
St Francis Xavier University (Nova Scotia, Canada)
Uploads
Papers by AMIT KOLI
Clinical Transplantation, 1988
Peer reviewe
Diabetes Care, Nov 1, 1985
Medecine Et Hygiene, 1983
Le SIDA reste une affection mortelle survenant dans certains groupes humains à haut risque qui so... more Le SIDA reste une affection mortelle survenant dans certains groupes humains à haut risque qui sont actuellement bien connus. L'agent responsable pourrait être un rétrovirus. L'évolution se caractérise par des infections opportunistes graves (P. Carinii, T. Gondii, C. Neoformans) et/ou l'apparition d'un sarcome de Kaposi de haut degré de malignité. Au-del) du traitement des infections et du sarcome de Kaposi, la restauration de l'immunité cellulaire reste l'objectif prinicpal. Dans cette perspective, des essais sont actuellement en cours utilisant l'interféron, les hormones thymiques ou l'interleukine 2.Peer reviewe
Revue médicale de Liège, 1988
Ever since India opened up its patent regime in January 2005 to include product patents in the fi... more Ever since India opened up its patent regime in January 2005 to include product patents in the field of pharmaceuticals, the patent law in this domain has kept alive the interest of various stakeholders. This is rightly so, since India is also known as the pharmacy of the world and is a global market leader in the export of generic drugs to the United States and Japan, as well as to countries in Africa and Europe. The Indian generic pharmaceutical industry had a turnover of US$11 billion in 2010, registering a growth rate of 22 per cent. During 2013–2014, pharmaceutical exports stood at Rs 90 000 crores (US$14.55 billion). Also, India is one of the largest consumers of medicines in the world, even though accessibility of medicines across economically weaker sections remains an issue. The Indian patent regime is well equipped to balance the quid-pro-quo requirement of patents. Even though jurisprudence in this field is still evolving, recent judicial precedents have reaffirmed that t...
Journal of Intellectual Property Law & Practice, 2015
Clinical Transplantation, 1988
Peer reviewe
Diabetes Care, Nov 1, 1985
Medecine Et Hygiene, 1983
Le SIDA reste une affection mortelle survenant dans certains groupes humains à haut risque qui so... more Le SIDA reste une affection mortelle survenant dans certains groupes humains à haut risque qui sont actuellement bien connus. L'agent responsable pourrait être un rétrovirus. L'évolution se caractérise par des infections opportunistes graves (P. Carinii, T. Gondii, C. Neoformans) et/ou l'apparition d'un sarcome de Kaposi de haut degré de malignité. Au-del) du traitement des infections et du sarcome de Kaposi, la restauration de l'immunité cellulaire reste l'objectif prinicpal. Dans cette perspective, des essais sont actuellement en cours utilisant l'interféron, les hormones thymiques ou l'interleukine 2.Peer reviewe
Revue médicale de Liège, 1988
Ever since India opened up its patent regime in January 2005 to include product patents in the fi... more Ever since India opened up its patent regime in January 2005 to include product patents in the field of pharmaceuticals, the patent law in this domain has kept alive the interest of various stakeholders. This is rightly so, since India is also known as the pharmacy of the world and is a global market leader in the export of generic drugs to the United States and Japan, as well as to countries in Africa and Europe. The Indian generic pharmaceutical industry had a turnover of US$11 billion in 2010, registering a growth rate of 22 per cent. During 2013–2014, pharmaceutical exports stood at Rs 90 000 crores (US$14.55 billion). Also, India is one of the largest consumers of medicines in the world, even though accessibility of medicines across economically weaker sections remains an issue. The Indian patent regime is well equipped to balance the quid-pro-quo requirement of patents. Even though jurisprudence in this field is still evolving, recent judicial precedents have reaffirmed that t...
Journal of Intellectual Property Law & Practice, 2015